INT316162

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.18
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 0.28
Pain Relevance 1.71

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (TCF21) DNA binding (TCF21)
Anatomy Link Frequency
blood 4
TCF21 (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 68 96.04 Very High Very High Very High
Pain 4 73.56 Quite High
Morphine 4 73.12 Quite High
analgesia 4 70.40 Quite High
Paracetamol 4 69.28 Quite High
Inflammation 52 65.28 Quite High
Versed 4 45.08 Quite Low
antagonist 16 40.96 Quite Low
cva 12 19.64 Low Low
Inflammatory response 24 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pain 4 73.56 Quite High
INFLAMMATION 64 65.28 Quite High
Hypersensitivity 4 39.60 Quite Low
Infection 20 28.32 Quite Low
Renal Failure 4 24.00 Low Low
Pulmonary Disease 4 23.40 Low Low
Myocardial Infarction 8 21.16 Low Low
Cv General 3 Under Development 12 19.64 Low Low
Diabetes Mellitus 4 18.96 Low Low
Hypertension 4 18.20 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Figure 3A shows that in AAS patients, HLA-DR expression on CD14HIGHcells was reduced after blood reperfusion (T4) (-49%) and continued to decrease by POD1 (-60%) and POD2 (-73%).
Localization (decrease) of POD1 in blood
1) Confidence 0.18 Published 2010 Journal Crit Care Section Body Doc Link PMC2887183 Disease Relevance 0.06 Pain Relevance 0.47
Figure 3A shows that in AAS patients, HLA-DR expression on CD14HIGHcells was reduced after blood reperfusion (T4) (-49%) and continued to decrease by POD1 (-60%) and POD2 (-73%).
Localization (decrease) of POD2 in blood
2) Confidence 0.18 Published 2010 Journal Crit Care Section Body Doc Link PMC2887183 Disease Relevance 0.07 Pain Relevance 0.47
Blood samples from patients were collected into sodium citrate vacuum tubes as follows: immediately before anesthesia induction (T1); before incision (T2), before vascular clamping (aortic clamping (AAS patients) or carotid artery clamping (CAS patients)) (T3), after blood reperfusion (T4) during the surgery, and on postoperative Days 1 (POD1) and 2 (POD2) after the surgery.
Localization (on) of POD1 in blood associated with anesthesia
3) Confidence 0.18 Published 2010 Journal Crit Care Section Body Doc Link PMC2887183 Disease Relevance 0.07 Pain Relevance 0.38
Blood samples from patients were collected into sodium citrate vacuum tubes as follows: immediately before anesthesia induction (T1); before incision (T2), before vascular clamping (aortic clamping (AAS patients) or carotid artery clamping (CAS patients)) (T3), after blood reperfusion (T4) during the surgery, and on postoperative Days 1 (POD1) and 2 (POD2) after the surgery.
Localization (on) of POD2 in blood associated with anesthesia
4) Confidence 0.16 Published 2010 Journal Crit Care Section Body Doc Link PMC2887183 Disease Relevance 0.07 Pain Relevance 0.38

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox